Literature DB >> 33671471

An Evidence-Based Systematic Review of Human Knee Post-Traumatic Osteoarthritis (PTOA): Timeline of Clinical Presentation and Disease Markers, Comparison of Knee Joint PTOA Models and Early Disease Implications.

Christine M Khella1, Rojiar Asgarian1, Judith M Horvath1, Bernd Rolauffs1, Melanie L Hart1.   

Abstract

Understanding the causality of the post-traumatic osteoarthritis (PTOA) disease process of the knee joint is important for diagnosing early disease and developing new and effective preventions or treatments. The aim of this review was to provide detailed clinical data on inflammatory and other biomarkers obtained from patients after acute knee trauma in order to (i) present a timeline of events that occur in the acute, subacute, and chronic post-traumatic phases and in PTOA, and (ii) to identify key factors present in the synovial fluid, serum/plasma and urine, leading to PTOA of the knee in 23-50% of individuals who had acute knee trauma. In this context, we additionally discuss methods of simulating knee trauma and inflammation in in vivo, ex vivo articular cartilage explant and in vitro chondrocyte models, and answer whether these models are representative of the clinical inflammatory stages following knee trauma. Moreover, we compare the pro-inflammatory cytokine concentrations used in such models and demonstrate that, compared to concentrations in the synovial fluid after knee trauma, they are exceedingly high. We then used the Bradford Hill Framework to present evidence that TNF-α and IL-6 cytokines are causal factors, while IL-1β and IL-17 are credible factors in inducing knee PTOA disease progresssion. Lastly, we discuss beneficial infrastructure for future studies to dissect the role of local vs. systemic inflammation in PTOA progression with an emphasis on early disease.

Entities:  

Keywords:  Bradford Hill; IL-17; IL-1β; IL-6; TNF-α; acute; articular cartilage; cartilage; cartilage repair; chondrocyte; chronic; clinical; complement; early PTOA; early disease; immunomodulation; in vitro models; inflammation; inflammatory cytokines; injury; knee joint; knee trauma; osteoarthritis; post-traumatic osteoarthritis; subacute; synovial fluid

Mesh:

Substances:

Year:  2021        PMID: 33671471      PMCID: PMC7922905          DOI: 10.3390/ijms22041996

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  275 in total

1.  Quantitative Mass Spectrometry To Study Inflammatory Cartilage Degradation and Resulting Interactions with the Complement System.

Authors:  Camilla Melin Fürst; Emma Åhrman; Klas Bratteby; Sofia Waldemarson; Johan Malmström; Anna M Blom
Journal:  J Immunol       Date:  2016-09-14       Impact factor: 5.422

2.  Crucial role of the terminal complement complex in chondrocyte death and hypertrophy after cartilage trauma.

Authors:  J Riegger; M Huber-Lang; R E Brenner
Journal:  Osteoarthritis Cartilage       Date:  2020-01-22       Impact factor: 6.576

3.  Serum Urate Levels Predict Joint Space Narrowing in Non-Gout Patients With Medial Knee Osteoarthritis.

Authors:  Svetlana Krasnokutsky; Charles Oshinsky; Mukundan Attur; Sisi Ma; Hua Zhou; Fangfei Zheng; Meng Chen; Jyoti Patel; Jonathan Samuels; Virginia C Pike; Ravinder Regatte; Jenny Bencardino; Leon Rybak; Steven Abramson; Michael H Pillinger
Journal:  Arthritis Rheumatol       Date:  2017-04-28       Impact factor: 10.995

4.  TSG-6 activity as a novel biomarker of progression in knee osteoarthritis.

Authors:  H-G Wisniewski; E Colón; V Liublinska; R J Karia; T V Stabler; M Attur; S B Abramson; P A Band; V B Kraus
Journal:  Osteoarthritis Cartilage       Date:  2013-12-12       Impact factor: 6.576

5.  Anaphylatoxin receptors and complement regulatory proteins in human articular and non-articular chondrocytes: interrelation with cytokines.

Authors:  Gundula Schulze-Tanzil; Benjamin Kohl; Karym El Sayed; Stephan Arens; Wolfgang Ertel; Katharina Stölzel; Thilo John
Journal:  Cell Tissue Res       Date:  2012-10-03       Impact factor: 5.249

6.  The effect of vascular endothelial growth factor on aggrecan and type II collagen expression in rat articular chondrocytes.

Authors:  Xuan-Yin Chen; Ya-Rong Hao; Zhe Wang; Jian-Lin Zhou; Qi-Xue Jia; Bo Qiu
Journal:  Rheumatol Int       Date:  2011-11-02       Impact factor: 2.631

7.  Increased expression of damage-associated molecular patterns (DAMPs) in osteoarthritis of human knee joint compared to hip joint.

Authors:  John H Rosenberg; Vikrant Rai; Matthew F Dilisio; Todd D Sekundiak; Devendra K Agrawal
Journal:  Mol Cell Biochem       Date:  2017-06-01       Impact factor: 3.396

Review 8.  Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases.

Authors:  Claudio Franceschi; Judith Campisi
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-06       Impact factor: 6.053

Review 9.  Secukinumab for ankylosing spondylitis and psoriatic arthritis.

Authors:  Ennio Lubrano; Fabio Massimo Perrotta
Journal:  Ther Clin Risk Manag       Date:  2016-10-21       Impact factor: 2.423

10.  Activin A/BMP2 chimera AB235 drives efficient redifferentiation of long term cultured autologous chondrocytes.

Authors:  G Jiménez; E López-Ruiz; W Kwiatkowski; E Montañez; F Arrebola; E Carrillo; P C Gray; J C Izpisua Belmonte; S Choe; M Perán; J A Marchal
Journal:  Sci Rep       Date:  2015-11-13       Impact factor: 4.379

View more
  8 in total

1.  Treatment of Large Cartilage Defects in the Knee by Hydrogel-Based Autologous Chondrocyte Implantation: Two-Year Results of a Prospective, Multicenter, Single-Arm Phase III Trial.

Authors:  P Niemeyer; M Hanus; J Belickas; T László; R Gudas; M Fiodorovas; A Cebatorius; M Pastucha; P Hoza; K Magos; K Izadpanah; L Paša; G Vásárhelyi; K Sisák; M Mohyla; C Farkas; O Kessler; S Kybal; R Spiro; A Köhler; A Kirner; S Trattnig; C Gaissmaier
Journal:  Cartilage       Date:  2022 Jan-Mar       Impact factor: 3.117

2.  Urocortin-1 Is Chondroprotective in Response to Acute Cartilage Injury via Modulation of Piezo1.

Authors:  Rebecca C Jones; Kevin M Lawrence; Scott M Higgins; Stephen M Richardson; Paul A Townsend
Journal:  Int J Mol Sci       Date:  2022-05-04       Impact factor: 6.208

3.  A single step, centrifuge-free method to harvest bone marrow highly concentrated in mesenchymal stem cells: results of a pilot trial.

Authors:  Marco Viganò; Enrico Ragni; Berardo Di Matteo; Francesco Manlio Gambaro; Carlotta Perucca Orfei; Giuseppina Spinelli; Alessandra Colombini; Laura de Girolamo; Elizaveta Kon
Journal:  Int Orthop       Date:  2021-11-02       Impact factor: 3.479

4.  Long-Term Incidence of Total Knee Arthroplasty after Open Reduction and Internal Fixation of Proximal Tibial and Distal Femoral Fractures: A Nationwide Cohort Study.

Authors:  Kuang-Ting Yeh; Wen-Tien Wu; Ru-Ping Lee; Chen-Chie Wang; Jen-Hung Wang; Ing-Ho Chen
Journal:  J Clin Med       Date:  2021-12-02       Impact factor: 4.241

Review 5.  Post-traumatic knee osteoarthritis; the role of inflammation and hemarthrosis on disease progression.

Authors:  Bob J Evers; Martijn H J Van Den Bosch; Arjen B Blom; Peter M van der Kraan; Sander Koëter; Rogier M Thurlings
Journal:  Front Med (Lausanne)       Date:  2022-08-22

6.  Modeling early changes associated with cartilage trauma using human-cell-laden hydrogel cartilage models.

Authors:  Chunrong He; Karen L Clark; Jian Tan; Hecheng Zhou; Rocky S Tuan; Hang Lin; Song Wu; Peter G Alexander
Journal:  Stem Cell Res Ther       Date:  2022-08-04       Impact factor: 8.079

7.  Application Value of Total Knee Arthroplasty plus Platelet-Rich Plasma Therapy in Traumatic Arthritis of the Knee.

Authors:  Canhong Zhang; Pengfei Nie
Journal:  Comput Math Methods Med       Date:  2022-09-26       Impact factor: 2.809

8.  Regenerative Potential of Platelet Concentrate Lysate in Mechanically Injured Cartilage and Matrix-Associated Chondrocyte Implantation In Vitro.

Authors:  Jan-Tobias Weitkamp; Bernd Rolauffs; Moritz Feldheim; Andreas Bayer; Sebastian Lippross; Matthias Weuster; Ralf Smeets; Hendrik Naujokat; Alan Jay Grodzinsky; Bodo Kurz; Peter Behrendt
Journal:  Int J Mol Sci       Date:  2021-12-07       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.